Ingrid Carvo

1.4k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Ingrid Carvo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Ingrid Carvo has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Ingrid Carvo's work include Renal cell carcinoma treatment (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Genomics and Diagnostics (4 papers). Ingrid Carvo is often cited by papers focused on Renal cell carcinoma treatment (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Genomics and Diagnostics (4 papers). Ingrid Carvo collaborates with scholars based in United States, Saudi Arabia and Israel. Ingrid Carvo's co-authors include Sabina Signoretti, Jiaxi Song, Gordon J. Freeman, Marcella Callea, Toni K. Choueiri, André P. Fay, F. Stephen Hodi, Michael B. Atkins, David F. McDermott and Laurence Albigès and has published in prestigious journals such as Nature, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Ingrid Carvo

15 papers receiving 1.1k citations

Hit Papers

On-target efficacy of a HIF-2α antagonist in preclinical ... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid Carvo United States 11 533 504 457 391 174 15 1.1k
Zishuo I. Hu United States 11 378 0.7× 748 1.5× 415 0.9× 217 0.6× 225 1.3× 12 1.2k
Jia Luo United States 15 458 0.9× 528 1.0× 288 0.6× 328 0.8× 97 0.6× 64 1.0k
Yozo Kawano Japan 19 331 0.6× 435 0.9× 362 0.8× 657 1.7× 97 0.6× 28 1.2k
Martina Kluth Germany 22 644 1.2× 327 0.6× 415 0.9× 768 2.0× 110 0.6× 75 1.3k
Zongwu Lin China 24 532 1.0× 341 0.7× 297 0.6× 602 1.5× 186 1.1× 61 1.3k
Satoshi Muto Japan 18 311 0.6× 406 0.8× 223 0.5× 246 0.6× 121 0.7× 72 898
Akira Ooki Japan 20 456 0.9× 617 1.2× 303 0.7× 595 1.5× 331 1.9× 98 1.4k
Dongsheng Yue China 22 665 1.2× 716 1.4× 372 0.8× 458 1.2× 130 0.7× 69 1.4k
Pierre Bohanes United States 16 266 0.5× 592 1.2× 205 0.4× 350 0.9× 213 1.2× 52 1.0k
Yasir Y. Elamin United States 16 518 1.0× 595 1.2× 164 0.4× 284 0.7× 127 0.7× 68 968

Countries citing papers authored by Ingrid Carvo

Since Specialization
Citations

This map shows the geographic impact of Ingrid Carvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Carvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Carvo more than expected).

Fields of papers citing papers by Ingrid Carvo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Carvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Carvo. The network helps show where Ingrid Carvo may publish in the future.

Co-authorship network of co-authors of Ingrid Carvo

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Carvo. A scholar is included among the top collaborators of Ingrid Carvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Carvo. Ingrid Carvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Li, Chia‐Cheng, et al.. (2020). Architectural Alterations in Oral Epithelial Dysplasia are Similar in Unifocal and Proliferative Leukoplakia. Head and Neck Pathology. 15(2). 443–460. 19 indexed citations
2.
Woo, Sook‐Bin, Hervé Sroussi, Ingrid Carvo, et al.. (2019). Oral immune‐related adverse events associated with PD‐1 inhibitor therapy: A case series. Oral Diseases. 26(2). 325–333. 36 indexed citations
3.
Cho, Hyejin, Xinlin Du, James P. Rizzi, et al.. (2016). On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models. Nature. 539(7627). 107–111. 336 indexed citations breakdown →
4.
Mahoney, Kathleen M., Susanna Jacobus, Rupal S. Bhatt, et al.. (2016). Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 14(4). 304–313.e6. 9 indexed citations
5.
Yuan, Qing, Payal Kapur, Yin Xi, et al.. (2016). Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor Cellularity. Clinical Genitourinary Cancer. 14(6). e585–e594. 27 indexed citations
6.
Callea, Marcella, Laurence Albigès, Mamta Gupta, et al.. (2015). Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma. Cancer Immunology Research. 3(10). 1158–1164. 266 indexed citations
7.
Fay, André P., Sabina Signoretti, Marcella Callea, et al.. (2015). Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study. Journal for ImmunoTherapy of Cancer. 3(1). 3–3. 73 indexed citations
8.
Kapur, Payal, Qing Yuan, Yin Xi, et al.. (2015). Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments. Clinical Genitourinary Cancer. 14(1). e25–e36. 41 indexed citations
9.
Pignon, Jean‐Christophe, Chiara Grisanzio, Ingrid Carvo, et al.. (2015). Cell Kinetic Studies Fail to Identify Sequentially Proliferating Progenitors as the Major Source of Epithelial Renewal in the Adult Murine Prostate. PLoS ONE. 10(5). e0128489–e0128489. 5 indexed citations
10.
Lowe, Alarice, Jean‐Christophe Pignon, Ingrid Carvo, et al.. (2015). Young investigator challenge: Application of cytologic techniques to circulating tumor cell specimens: Detecting activation of the oncogenic transcription factor STAT3. Cancer Cytopathology. 123(12). 696–706. 13 indexed citations
11.
Choueiri, Toni K., André P. Fay, Kathryn P. Gray, et al.. (2014). PD-L1 expression in nonclear-cell renal cell carcinoma. Annals of Oncology. 25(11). 2178–2184. 242 indexed citations
12.
Fay, André P., Marcella Callea, Kathryn P. Gray, et al.. (2014). PD-L1 expression in non-clear cell renal cell carcinoma.. Journal of Clinical Oncology. 32(4_suppl). 424–424. 11 indexed citations
13.
Callea, Marcella, Elizabeth M. Genega, Mamta Gupta, et al.. (2014). PD-L1 expression in primary clear cell renal cell carcinomas (ccRCCs) and their metastases.. Journal of Clinical Oncology. 32(4_suppl). 467–467. 26 indexed citations
14.
Callea, Marcella, Elizabeth M. Genega, Su–Chun Cheng, et al.. (2014). PD-L1 expression in primary clear cell renal cell carcinomas (ccRCCs) and their metastases.. Journal of Clinical Oncology. 32(15_suppl). 4585–4585. 6 indexed citations
15.
Fay, André P., Marcella Callea, Kathryn P. Gray, et al.. (2014). PD-L1 expression in non-clear cell renal cell carcinoma and benign kidney tumors.. Journal of Clinical Oncology. 32(15_suppl). 4526–4526. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026